abstract |
the present invention relates to a pharmaceutical composition of a kor receptor agonist, comprising 4-amino-n- [n2- [n- [n- [n - ((r) -2-phenyl propyl) glycyl] -d -phenylalanyl] -d-leucyl] -d-lisl] piperidine-4-carboxylic acid, or salts thereof, and an acetate buffer solution. |